The UAE is positioning itself as a global reference point for pharmaceutical innovation, driven by regulatory maturity, public-private collaboration, and a clear commitment to advancing healthcare, ...
Basel, March 27, 2026 – Novartis today announced that it has entered into an agreement to acquire Excellergy, Inc., a private biotech company developing next-generation anti-IgE therapies for ...
Approval expands treatment options for eligible adults with HR+/HER2− stage II and III early breast cancer at high risk of recurrence1 ...